3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Breast Neoplasms
2321
Neoplasms
1688
Prostatic Neoplasms
1187
Lung Neoplasms
914
Colorectal Neoplasms
875
Carcinoma, Non-Small-Cell Lung
849
Leukemia, Myeloid, Acute
585
Pancreatic Neoplasms
573
Multiple Myeloma
545
Carcinoma, Hepatocellular
515
Brain Neoplasms
513
Neoplasm Metastasis
462
Head and Neck Neoplasms
459
Melanoma
414
Ovarian Neoplasms
409
Glioblastoma
399
Precursor Cell Lymphoblastic Leukemia-Lymphoma
388
Stomach Neoplasms
371
Uterine Cervical Neoplasms
359
Squamous Cell Carcinoma of Head and Neck
356
Rectal Neoplasms
335
Recurrence
334
Hematologic Neoplasms
327
Sarcoma
324
Lymphoma
314
Colonic Neoplasms
314
Triple Negative Breast Neoplasms
285
Urinary Bladder Neoplasms
283
Glioma
278
Carcinoma, Renal Cell
278
Interventions
pembrolizumab
1
osimertinib
1
binimetinib
1
Pemetrexed
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Non-small Cell Carcinoma
×
1 year
×
Clear all
NCT03991819
2025-12-05
BiniPembro
University Health Network, Toronto
Phase 1
Recruiting
40 enrolled
NCT04695925
2025-10-15
TOP
Sun Yat-sen University
Phase 3
Active not recruiting
294 enrolled